Panacea Biotech Q2FY17

1. Net Loss At Rs 11.8 cr v/s Loss Of Rs 17 cr (YoY)
2. Total Income Down 16.7% At Rs 137.2 cr v/s Rs 164.8 cr (YoY) 
3. EBITDA Down 59% At Rs 10.3 cr v/s Rs 25.1 cr (YoY) 
4. EBITDA Margin At 7.5% v/s 15.2% (YoY)